NASDAQ:BEAM | Free Cash Flow | Beam Therapeutics Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$128.51M$2.23M-$130.75M
2025-12-31-$83.29M$3.73M-$87.02M-35.62%
2025-03-31-$103.88M$3.07M-$106.95M
2024-12-31-$76.37M$2.97M-$79.34M
2024-03-31-$99.75M$2.44M-$102.19M
2023-12-31$135.07M$3.59M$131.48M92.08%
2023-03-31-$109.82M$6.02M-$115.83M
2022-12-31-$69.19M$8.26M-$77.45M
2022-03-31$218.49M$7.26M$211.23M
2021-12-31$1.83M$13.37M-$11.54M
2021-03-31-$38.58M$11.48M-$50.06M
2020-12-31-$24.3M$8.13M-$32.42M
2020-03-31-$27.39M$3.05M-$30.44M
2019-12-31-$17.8M$2.16M-$19.96M
2019-03-31-$25.86M$2.35M-$28.21M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$345.1M$14.95M-$360.05M
2024-12-31-$347.25M$8.95M-$356.19M
2023-12-31-$149.2M$33.73M-$182.93M
2022-12-31$22.53M$48.95M-$26.42M
2021-12-31-$66.27M$46.81M-$113.08M
2020-12-31-$95.74M$16.36M-$112.1M
2019-12-31-$72M$12.52M-$84.52M